General Information of Drug (ID: DMBMTGP)

Drug Name
ISIS 9064 Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
TTD Drug ID
DMBMTGP

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
RG7304 DMGFAVQ Solid tumour/cancer 2A00-2F9Z Phase 1 [2]
ISIS 9065 DMH50RX Discovery agent N.A. Investigative [1]
ISIS 9063 DM8E5RO Discovery agent N.A. Investigative [1]
ISIS 10228 DMESKQX Discovery agent N.A. Investigative [3]
ISIS 9061 DMFAL2E Discovery agent N.A. Investigative [1]
ISIS 9071 DMWY2XB Discovery agent N.A. Investigative [1]
ISIS 9060 DMZL7SW Discovery agent N.A. Investigative [1]
ISIS 9070 DMU0HQF Discovery agent N.A. Investigative [1]
ISIS 9069 DM5C86M Discovery agent N.A. Investigative [1]
ISIS 9067 DML8HCZ Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
A-Raf messenger RNA (ARAF mRNA) TT5TURO ARAF_HUMAN Not Available [1]

References

1 US patent application no. 5,563,255, Antisense oligonucleotide modulation of raf gene expression.
2 Clinical pipeline report, company report or official report of Roche.
3 US patent application no. 5,952,229, Antisense oligonucleotide modulation of raf gene expression.